This site has been optimized to work with modern browsers and does not fully support your version of Internet Explorer.

Genetic test predicts men’s risk of developing prostate cancer

Predictive genetic tool developed to better inform men whether and when to take PSA blood test.

Prostate cancer detection currently relies on the prostate-specific antigen (PSA) screening blood test, which has been proven to reduce deaths from the disease. However, PSA testing is a poor screening tool because it can also produce false positive results and encourages over-detection of non-aggressive, slow-growing tumors.

For the full story on the University of Oxford website